Is ANI Pharmaceuticals, Inc. overvalued?

ANI Pharmaceuticals, Inc. (ANIP) looks undervalued — trading about 205% below its fair value.

Undervalued

Price

$75.81

Fair value

$231.10

Current P/E

9.2

Normal P/E

28.1

Market cap

$1.72B

Dividend yield

0.0%

Return on equity

19.2%

Sector

Healthcare

Fair value compares ANIP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks